Published in:
Open Access
01-12-2021 | Melanoma | Research
Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers
Authors:
Hiva Alipanah, Mojtaba Farjam, Elham Zarenezhad, Ghazaal Roozitalab, Mahmoud Osanloo
Published in:
BMC Complementary Medicine and Therapies
|
Issue 1/2021
Login to get access
Abstract
Background
Melanoma and breast cancers are two common cancers worldwide. Due to the side effects of chemotherapy drugs and the occurring resistance against them, the development of green drugs has been received more attention.
Methods
The anticancer effects of three essential oils from the Citrus family and their identified major constituents (limonene) were first investigated against melanoma and breast cancer cell lines (A-375 and MDA-MB-468). By preparing chitosan nanoparticles containing them, an attempt was then made to improve their effectiveness.
Results
Chitosan nanoparticles containing Citrus sinensis and Citrus limon essential oils with IC50s of 0.03 and 0.124 μg/mL on A-375 cells, and 23.65 and 40.32 μg/mL on MDA-MB-468 showed distinct anticancer efficacies.
Conclusion
The prepared formulations could thus be considered as green anticancer agents in complementary medicine and therapies.